News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
LYNCH DANIEL
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/15/2023 |
4
| LYNCH DANIEL (Director) has filed a Form 4 on 2seventy bio, Inc.|
Txns:
| Granted 8,400 shares
@ $0
Granted 16,900 options to buy
@ $11.81, valued at
$199.6k
|
|
| 05/25/2023 |
4
| LYNCH DANIEL (Director) has filed a Form 4 on SpringWorks Therapeutics, Inc.|
Txns:
| Granted 4,648 shares
@ $0
Granted 13,774 options to buy
@ $32.27, valued at
$444.5k
|
|
| 06/09/2022 |
4
| LYNCH DANIEL (Director) has filed a Form 4 on 2seventy bio, Inc.|
Txns:
| Granted 7,200 shares
@ $0
Granted 14,400 options to buy
@ $13.51, valued at
$194.5k
|
|
| 05/20/2022 |
4
| LYNCH DANIEL (Director) has filed a Form 4 on SpringWorks Therapeutics, Inc.|
Txns:
| Granted 4,818 shares
@ $0
Granted 15,318 options to buy
@ $35.42, valued at
$542.6k
|
|
| 11/17/2021 |
4
| LYNCH DANIEL (Director) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Disposed of 23,342 options to buy
@ $0
Disposed of 10,500 options to buy
@ $0
Disposed of 5,600 options to buy
@ $0
Disposed of 4,200 options to buy
@ $0
Disposed of 7,000 options to buy
@ $0 |
|
| 11/16/2021 |
4
| LYNCH DANIEL (Director) has filed a Form 4 on 2seventy bio, Inc.|
Txns:
| Granted 2,803 shares
@ $0
Granted 7,660 options to buy
@ $8.55, valued at
$65.5k
Granted 3,445 options to buy
@ $39.07, valued at
$134.6k
Granted 3,445 options to buy
@ $287.25, valued at
$989.6k
Granted 1,837 options to buy
@ $74.34, valued at
$136.6k
Granted 1,837 options to buy
@ $172.37, valued at
$316.6k
Granted 1,837 options to buy
@ $284.33, valued at
$522.3k
Granted 1,837 options to buy
@ $189.47, valued at
$348.1k
Granted 1,378 options to buy
@ $99.53, valued at
$137.2k
Granted 4,507 options to buy
@ $50.98, valued at
$229.8k
|
|
| 10/21/2021 |
3
| LYNCH DANIEL (10% Owner) has filed a Form 3 on Xilio Therapeutics, Inc. |
| 10/18/2021 |
3
| LYNCH DANIEL (Director) has filed a Form 3 on 2seventy bio, Inc. |
| 06/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/21/2021 |
4
| LYNCH DANIEL (Director) has filed a Form 4 on SpringWorks Therapeutics, Inc.|
Txns:
| Granted 1,106 shares
@ $0
Granted 6,998 options to buy
@ $75.94, valued at
$531.4k
|
|
| 01/06/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/26/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/23/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/22/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/12/2020 |
4
| LYNCH DANIEL (Director) has filed a Form 4 on Surface Oncology, Inc.|
Txns:
| Granted 12,000 options to buy
@ $4.35, valued at
$52.2k
|
|
| 05/22/2020 |
4
| LYNCH DANIEL (10% Owner) has filed a Form 4 on SpringWorks Therapeutics, Inc.|
Txns:
| Granted 7,464 options to buy
@ $38.03, valued at
$283.9k
|
|
| 04/07/2020 |
4
| LYNCH DANIEL (Director) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Gifted 50,000 shares
@ $0 |
|
| 09/16/2019 |
4
| LYNCH DANIEL (Director) has filed a Form 4 on SpringWorks Therapeutics, Inc.|
Txns:
| Granted 29,983 options to buy
@ $18, valued at
$539.7k
|
|
| 09/12/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/21/2019 |
4
| LYNCH DANIEL (Director) has filed a Form 4 on Sesen Bio, Inc.|
Txns:
| Granted 52,500 options
@ $1.48, valued at
$77.7k
|
|
| 06/20/2019 |
4
| LYNCH DANIEL (Director) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Granted 4,875 options to buy
@ $96.77, valued at
$471.8k
Granted 1,312 restricted stock units
@ $0 |
|
| 06/19/2019 |
4
| LYNCH DANIEL (Director) has filed a Form 4 on Translate Bio, Inc.|
Txns:
| Granted 18,900 options to buy
@ $10.2, valued at
$192.8k
|
|
| 06/10/2019 |
4
| LYNCH DANIEL (Director) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Granted 1,400 shares
@ $0
Granted 5,600 options to buy
@ $122.01, valued at
$683.3k
|
|
| 06/06/2019 |
4
| LYNCH DANIEL (Director) has filed a Form 4 on Surface Oncology, Inc.|
Txns:
| Granted 12,100 options to buy
@ $3.69, valued at
$44.6k
|
|
| 06/27/2018 |
3
| LYNCH DANIEL (Director) has filed a Form 3 on Translate Bio, Inc. |
| 06/25/2018 |
4
| LYNCH DANIEL (Director) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Granted 7,500 options to buy
@ $69.79, valued at
$523.4k
|
|
| 06/22/2018 |
4
| LYNCH DANIEL (Director) has filed a Form 4 on bluebird bio, Inc.|
Txns:
| Granted 1,400 shares
@ $0
Granted 5,600 options to buy
@ $183.1, valued at
$1M
|
|
| 06/14/2018 |
4
| LYNCH DANIEL (Director) has filed a Form 4 on Sesen Bio, Inc.|
Txns:
| Granted 52,500 options
@ $2.24, valued at
$117.6k
|
|
| 04/18/2018 |
3
| LYNCH DANIEL (Director) has filed a Form 3 on Surface Oncology, Inc. |
| 02/16/2018 |
4
| LYNCH DANIEL (Director) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 12,500 shares
@ $80.42, valued at
$1M
|
|
| 02/14/2018 |
4
| LYNCH DANIEL (Director) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 1,530 shares
@ $77.18, valued at
$118.1k
Sold 2,590 shares
@ $75.96, valued at
$196.7k
Sold 5,636 shares
@ $75.15, valued at
$423.5k
Sold 3,748 shares
@ $74.31, valued at
$278.5k
Sold 3,996 shares
@ $73.27, valued at
$292.8k
|
|
| 11/17/2017 |
4
| LYNCH DANIEL (Director) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 1,600 shares
@ $64.15, valued at
$102.6k
Sold 2,200 shares
@ $63.25, valued at
$139.2k
Sold 1,200 shares
@ $62.59, valued at
$75.1k
|
|
| 09/20/2017 |
4
| LYNCH DANIEL (Director) has filed a Form 4 on Blueprint Medicines Corp|
Txns:
| Sold 2,500 shares
@ $60, valued at
$150k
|
|
|
|
|